0001140361-15-024569.txt : 20150617
0001140361-15-024569.hdr.sgml : 20150617
20150617155815
ACCESSION NUMBER: 0001140361-15-024569
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150615
FILED AS OF DATE: 20150617
DATE AS OF CHANGE: 20150617
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Emergent BioSolutions Inc.
CENTRAL INDEX KEY: 0001367644
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 141902018
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 400 PROFESSIONAL DR, SUITE 400
CITY: GAITHERSBURG
STATE: MD
ZIP: 20879
BUSINESS PHONE: 240-631-3200
MAIL ADDRESS:
STREET 1: 400 PROFESSIONAL DR, SUITE 400
CITY: GAITHERSBURG
STATE: MD
ZIP: 20879
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Havey Adam
CENTRAL INDEX KEY: 0001514588
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33137
FILM NUMBER: 15937172
MAIL ADDRESS:
STREET 1: 2273 RESEARCH BLVD SUITE 400
CITY: ROCKVILLE
STATE: MD
ZIP: 20853
4
1
doc1.xml
FORM 4
X0306
4
2015-06-15
0
0001367644
Emergent BioSolutions Inc.
EBS
0001514588
Havey Adam
400 PROFESSIONAL DR, SUITE 400
GAITHERSBURG
MD
20879
0
1
0
0
EVP, Biodefense Divison
Common Stock
2015-06-15
4
M
0
15919
14.67
A
57363
D
Common Stock
2015-06-15
4
S
0
15919
31.502
D
41444
D
Common Stock
2015-06-15
4
M
0
9773
15.83
A
51217
D
Common Stock
2015-06-15
4
S
0
9773
31.665
D
41444
D
Common Stock
2015-06-15
4
S
0
10606
31.502
D
30838
D
Stock Option
14.67
2015-06-15
4
M
0
15919
0
D
2010-03-11
Common Stock
15919
7960
D
Stock Option
15.83
2015-06-15
4
M
0
9773
0
D
2019-03-12
Common Stock
9773
0
D
Consists of an option granted under the company's stock incentive plan on March 12, 2013.
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Havey.
The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.055 to $31.77, inclusive.
Consists of an option granted under the company's stock incentive plan on March 13, 2012.
The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.66 to $31.72, inclusive.
The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.03 to $31.76, inclusive.
The option vested in three equal installments in March 2014, 2015 and 2016
The option vested in three equal installments in March 2013, 2014 and 2015.
/s/ Eric Burt, attorney-in-fact
2015-06-17